Long-term Safety Study of Alogliptin in Participants With Type 2 Diabetes in Japan

NCT01263496 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: Alogliptin
DRUG: Alogliptin
DRUG: Alogliptin
DRUG: Alogliptin
DRUG: Voglibose

Sponsor

Takeda